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The innate immune system has evolved endosomal and cytoplasmic receptors for the
detection of viral nucleic acids as sensors for virus infection. Some of these pattern
recognition receptors (PRR) detect features of viral nucleic acids that are not found
in the host such as long stretches of double-stranded RNA (dsRNA) and uncapped
single-stranded RNA (ssRNA) in case of Toll-like receptor (TLR) 3 and RIG-I, respectively.
In contrast, TLR7/8 and TLR9 are unable to distinguish between viral and self-nucleic
acids on the grounds of distinct molecular patterns. The ability of these endosomal TLR
to act as PRR for viral nucleic acids seems to rely solely on the mode of access to
the endolysosomal compartment in which recognition takes place. The current dogma
states that self-nucleic acids do not enter the TLR-sensing compartment under normal
physiological conditions. However, it is still poorly understood how dendritic cells (DC)
evade activation by self-nucleic acids, in particular with regard to specific DC subsets,
which are specialized in taking up material from dying cells for cross-presentation of
cell-associated antigens. In this review we discuss the current understanding of how the
immune system distinguishes between foreign and self-nucleic acids and point out some
of the key aspects that still require further research and clarification.
Keywords: endosomal toll-like receptors, nucleic acids, innate immune activation, autoimmunity, pattern
recognition
Viruses are dependent on the host metabolism for replication.
As a consequence of this, the carbohydrate and lipid structures
associated with viruses are very similar to those of the host and,
therefore, do not represent suitable pathogen-associated molec-
ular patterns (PAMP) for innate immune recognition. Instead,
the immune system has evolved pattern recognition receptors
(PRR) that recognize viral nucleic acids. Viral replication leads to
the accumulation of viral replication intermediates in the cyto-
plasm of infected cells, which trigger cytoplasmic PRR such as
the RIG-I-like receptors and various DNA sensors such as DAI,
DExD/H box family helicases, AIM2-like receptors and cGAS
(Kato et al., 2011; Keating et al., 2011; Sun et al., 2013; Wu et al.,
2013). These cytoplasmic nucleic acid-sensing PRR initiate the
local anti-viral response in the infected tissue. Cells of the innate
immune system are recruited to the site of infection and together
with local sentinels such as Langerhans cells and dermal dendritic
cells (DC) in the skin and interstitial DC in other organs sense
the infectious organism by means of PRR such as Toll-like recep-
tors (TLR), which sample exogenous material for the presence of
PAMP. PRR-mediated activation of DC by PAMP is thought to be
crucial for the initiation of an adaptive immune response against
the invading pathogen (Joffre et al., 2009). The requirement for
direct activation of DC via PRR ensures that only DC which had
direct contact to the infectious organism and present pathogen-
derived antigens have the capacity to induce the differentiation of
T cells into effector cells. However, in particular situations, indi-
rect activation of DC via inflammasome-induced IL-1β seems to
be sufficient to promote the induction of an adaptive immune
response as observed upon live influenza A or herpes simplex
virus infection inmice (Pang et al., 2013). Similarly, in house dust
mite allergen-induced asthma direct TLR-mediated activation is
dispensable (Hammad et al., 2009) and it is currently unclear
which mechanism allows the immune system to repeal the need
for direct activation of DC.
Recognition by cytoplasmic PRR partially depends on fea-
tures of viral nucleic acids that are absent from mammalian
nucleic acids such as 5′ triphosphate groups on short blunt-ended
double-stranded RNA (dsRNA) structures recognized by RIG-I
and long dsRNA structures recognized by MDA5 (Goubau et al.,
2013). However, cytosolic DNA sensors are thought to be unable
to distinguish between foreign and self DNA since it was shown
that recognition is sequence-independent and unaffected by
nucleic acid modifications such as methylation (Ishii et al., 2006;
Stetson and Medzhitov, 2006). Furthermore, while DAI (also
called DLM-1/ZBP1) was initially described as a Z-DNA-binding
protein recognizing the rare left-handed Z-form of DNA associ-
ated with some viral structures, it was later demonstrated that
the right-handed B-form of DNA as seen for self DNA and most
commonly found under physiological conditions has the capacity
to trigger a cytoplasmic DNA sensor upstream of the stimulator
of interferon (IFN) genes (STING) (Schwartz et al., 2001; Ishii
et al., 2006; Takaoka et al., 2007). In line with the hypothesis
that cytoplasmic sensors are not specific for foreign DNA struc-
tures, self DNA induces polyarthritis in mice deficient for DNase
II and type I interferon (IFN-I) receptor in a STING-dependent
manner (Ahn et al., 2012). Similarly, TLR-mediated recognition
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of nucleic acids relies on molecular patterns that are present in
self-nucleic acids as discussed later inmore detail (Hornung et al.,
2006; Pichlmair et al., 2006; Takaoka et al., 2007). This shows
that the immune system has evolved mechanisms to prevent stim-
ulation by self-nucleic acids under normal conditions, but that
nucleic acid-sensing PRR can trigger innate immune activation
in pathological situations. Thus, aberrant PRR activation by self-
nucleic acids poses the risk of driving autoimmunity induction.
In this review, we will discuss the current understanding of how
the immune system distinguishes between viral vs. self-nucleic
acids on the level of endosomal TLR and which mechanisms
are involved in preventing autoimmunity induction driven by
TLR-mediated sensing of self-nucleic acids under physiological
conditions.
ENDOSOMAL TOLL-LIKE RECEPTORS AND THEIR AGONISTS
The family of endosomal nucleic acid-sensing TLR comprises
TLR3, TLR7, TLR8, and TLR9 (Figure 1). While TLR7–9 form all
endosomal TLR dependent on the endoplasmic reticulum (ER)-
resident protein UNC93B1 for trafficking from the ER via the
Golgi to the endolysosomal compartment (Figure 3A) (Du et al.,
2000; Brinkmann et al., 2007; Kim et al., 2008). Other factors
that affect the trafficking of endosomal TLR are the ER chaper-
one GP96 and PRAT4A (Randow and Seed, 2001; Takahashi et al.,
2007; Yang et al., 2007b). For a comprehensive review on TLR
trafficking see the review by Lee et al. (2012).
In addition, differential recruitment of adaptor protein com-
plexes (AP) affects post-Golgi trafficking of endosomal TLR.
While AP-2 recruitment by TLR9 enables its translocation from
the plasma membrane to the endolysosomal compartment, TLR7
trafficking is independent of AP-2 and does not involve transient
localization to the plasma membrane, but instead is dependent
on AP-4 recruitment (Lee et al., 2013). TLR3 trafficking is again
distinct from TLR7 and TLR9 and is independent of PRAT4A
and not affected by mutations in UNC93B1 that impair TLR7
and TLR9 trafficking (Takahashi et al., 2007; Fukui et al., 2011).
Interestingly, cell specific differences in endosomal TLR traffick-
ing have also been reported. Trafficking of endosomal TLR in
plasmacytoid DC (PDC) is dependent on the recruitment of AP-3
and LC-3, which direct the localization of TLR7 and TLR9 to
an endosomal compartment specialized in inducing type I IFN
in these natural IFN-producing cells (Sasai et al., 2010; Henault
et al., 2012).
Once recruited to the endolysosomal compartment, the TLR
are rendered functionally active upon cleavage by resident pH-
dependent proteases (Ewald et al., 2008; Park et al., 2008). The
requirement for cleavage upon arrival in the endolysosomal com-
partment is thought to prevent activation of the nucleic acid-
sensing TLR by self-nucleic acids at other locations in the cell
or at the cell surface and is regarded as one of the mechanism
that prevent aberrant activation of these TLR by self-agonists
under physiological conditions. However, once the TLR have been
rendered functional through proteolytic cleavage, they cannot
distinguish between viral and self-nucleic acids on the basis of
structural differences with the exception of TLR3.
TLR3 recognizes viral dsRNA in a sequence-independent
manner in form of genomic dsRNA or dsRNA replication
FIGURE 1 | Access of agonists to endosomal nucleic acid-sensing TLR.
Endosomal TLR are situated in the membrane of the endolysosomal
compartment of APC and sample the content of these compartments for
the presence of nucleic acid agonists. Pathogens or dead cells gain access
to the compartment by endocytosis. Alternatively, infection-induced
autophagy can shuttle viral nucleic acids and antigens into the
endolysosomal compartment and allow for recognition of replicating virus
within infected cells by endosomal TLR.
intermediates present in virus-infected cells (Alexopoulou et al.,
2001; Schulz et al., 2005). Genomic nucleic acid material from
dsRNA viruses such as reoviruses and dsRNA replication inter-
mediates as produced for example by alphaviruses consist of long
stretches of dsRNA which represent molecular structures that
are absent from uninfected eukaryotic cells. Only short struc-
tures of dsRNA are found among cellular RNA such as in the
secondary clover-leaf structure of transfer RNA (tRNA) or in
microRNA (miRNA). As such, viral dsRNA represents a bona
fide PAMP that allows the immune system to distinguish between
viral and self RNAmolecules. A minimum length of 45 base pairs
(bp) is thought to be required for binding to TLR3, but dsRNA
molecules >90 bp show stronger induction of pro-inflammatory
cytokines (Leonard et al., 2008; Liu et al., 2008; Jelinek et al.,
2011). Surprisingly, 21 nucleotide-long small interfering RNA
(siRNA) molecules have been reported to trigger TLR3-mediated
activation in vitro and in vivo contradicting the requirement
for dsRNA stretches longer than 45 bp (Kariko et al., 2004a,b;
Kleinman et al., 2008). However, other reports failed to detect
innate immune activation by siRNAmolecules and, furthermore,
miRNA and endogenously expressed hairpin siRNA (shRNA) are
not immunogenic. These findings suggest that innate immune
activation in response to siRNA may represent an experimental
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artifact possibly due to the formation of higher order struc-
tures by siRNA preparations. Similarly, messenger RNA (mRNA)
was reported to induce TLR3 activation in experimental settings
whichmay be a consequence of using highly pure mRNAprepara-
tions devoid of RNA-binding proteins allowing for the formation
of higher order structures (Kariko et al., 2004c). Interestingly,
functional TLR3 has been detected at the cell surface rather
than in endosomes in human fibroblasts (Matsumoto et al.,
2003). While the role of TLR3 at the cell surface of fibroblasts
is entirely enigmatic, cell surface expression of this particular
dsRNA-sensing PRR may not pose an increased risk with regard
to autoimmunity induction, since dsRNA represents a bona fide
PAMP absent from mammalian cells.
In contrast to TLR3, the other endosomal TLR namely TLR7,
TLR8, and TLR9 are unable to distinguish between pathogen and
self-nucleic acids on the basis of distinct molecular structures
(Barbalat et al., 2011). Mouse TLR7 and human TLR7 and TLR8
serve as PRR for single-stranded RNA (ssRNA), whereas the func-
tionality of mouse TLR8 is still somewhat obscure (Alexopoulou
et al., 2012). In addition to viral ssRNA and synthetic uridine-
or uridine/guanosine-rich oligoribonucleotides (ORN), there is a
number of small immune modifiers developed by pharmaceuti-
cal companies with TLR7 and/or TLR8-stimulating activity such
as the imidazoquinolines R848 and R837 (Smits et al., 2008).
R837 is approved for topical application and is used for treat-
ment of genital warts and basal cell carcinoma because of its
TLR-mediated anti-viral and anti-tumouricidal activities, respec-
tively (Wagstaff and Perry, 2007). When RNA was first discov-
ered as the natural agonist of TLR7 and human TLR8, it was
immediately obvious that the preference for guanosine/uridine
(GU)-rich and uridine (U)-rich sequences by human and mouse
ssRNA-sensing TLR, respectively, did not constitute a suitable
basis for discrimination between pathogen-associated and self-
nucleic acids (Diebold et al., 2004; Heil et al., 2004). Furthermore,
mouse TLR7 was demonstrated to respond to ORN correspond-
ing to eukaryotic mRNA sequences and purified mouse mRNA,
showing that self-nucleic acid is immunostimulatory when deliv-
ered efficiently into the TLR7-sensing endosomal compartment
(Diebold et al., 2004, 2006). Interestingly, mammalian RNA con-
tains a high frequency of modifications such as methylated nucle-
osides or pseudouridines, which ablate TLR7 and TLR8 activation
(Kariko et al., 2005). Such modifications are particularly abun-
dant in mammalian tRNA and ribosomal RNA (rRNA) but less
frequent in mammalian mRNA (Soll, 1971; Maden and Hughes,
1997). This could explain why total mammalian RNA, which
contains a high percentage of RNA species with TLR-inhibitory
modifications is not immunostimulatory whereas purified mam-
malian mRNA when delivered to the endosome in form of
complexes with polycations such as polyethylenimine triggers
TLR7-dependent innate immune activation (Koski et al., 2004;
Kariko et al., 2005; Diebold et al., 2006). Further evidence that
TLR7 and human TLR8 cannot discriminate between self and
pathogen RNA on the basis of structural differences stems from
findings that implicate a central role for the recognition of self
RNA in the immunopathogenesis of autoimmune diseases such
as systemic lupus erythematosus (SLE), psoriasis, rheumatoid
arthritis, Sjörgen’s syndrome and others (Theofilopoulos et al.,
2011). Similarly, genetic modifications that lead to a duplication
of the TLR7 gene or over-expression of transgenic TLR7 are asso-
ciated with exacerbated lupus-like symptoms in murine models
(Pisitkun et al., 2006; Deane et al., 2007). It is worth noting that
TLR7 is located on the X chromosome and that females induce
higher levels of IFN-I in response to TLR7 agonists (Berghofer
et al., 2006), which could represent a major factor responsible for
the higher prevalence of SLE in women.
A similar link to autoimmunity induction has been identified
for TLR9 (Theofilopoulos et al., 2011). TLR9 has evolved as innate
immune sensor for viral, bacterial, fungal and protozoan DNA
and is also activated by synthetic oligodesoxyribonucleotides
(ODN) with a phosphorothioate backbone and an unmethy-
lated CpG motif (Bauer et al., 2001; Lund et al., 2003; Parroche
et al., 2007; Nakamura et al., 2008). Since the immunostimulatory
activity of ODN is dependent on the presence of an unmethylated
CpG motif and since such motifs are more abundant in bacterial
DNA than in mammalian DNA, it was thought for a long time
that TLR9 is able to discriminate between pathogen and self DNA
(Hemmi et al., 2000). However, further studies have questioned
the requirement for a CpG motif for TLR9-mediated activation
(Yasuda et al., 2006; Haas et al., 2008; Wagner, 2008). Using syn-
thetic TLR9 agonists, it was discovered that phosphorothioate
ODN have a much higher affinity to TLR9 than ODN with a
natural phosphodiester backbone and that the latter exert TLR9
stimulatory activity independent of the presence of CpG motives
(Haas et al., 2008). In direct contrast to this, when studying the
activation of autoreactive B cells it became apparent that TLR9
stimulation is dependent not only on the presence of CpG motifs
in mammalian DNA, but also on the hypomethylated status of
the self-nucleic acids (Viglianti et al., 2003). While it is currently
unclear how these conflicting results regarding the requirement
for unmethylated CpGmotives can be reconciled, it is evident that
self DNA has the ability to induce TLR9 activation if it enters the
endosomal compartment in which recognition takes place.
HOW DOES THE IMMUNE SYSTEM DISCRIMINATE
BETWEEN PATHOGEN AND SELF NUCLEIC ACIDS?
Once it became obvious that the nucleic acid structures recog-
nized by TLR7, TLR8, and TLR9 do not constitute bona fide
PAMP and that self-nucleic acids can trigger innate immune
activation via these PRR under certain conditions, it was hypoth-
esized that the endosomal localization of these TLR prevents acti-
vation by self-agonists under physiological conditions by refusing
self-nucleic acids access to the compartment (Diebold et al.,
2004; Heil et al., 2004; Barton et al., 2006; Barton and Kagan,
2009). According to this hypothesis, mechanisms that regulate the
uptake of material containing pathogen vs. self-nucleic acids must
be in place to prohibit innate immune activation in response to
the latter.
In this context it is worth remembering that experimental sys-
tems often fail tomimic natural processes in all details with regard
to innate immune activation by PAMP. In experimental systems,
agonists for endosomal TLR such as CpGODN, R848 and polyI:C
for TLR9, TLR7/8, and TLR3 activation, respectively, are admin-
istrated in solution whereas ORN for stimulation of TLR7/8 are
applied in form of complexes with polycations or cationic lipids
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such as polyethylenimine or DOTAP. In contrast, the natural ago-
nists for endosomal TLR are an integral part of pathogens includ-
ing viruses or virus-infected host cells and as such are not directly
accessible for receptor binding neither at the cell surface nor
in the endolysosomal compartment. Consequently, pathogen-
and host cell-derived material associated with pathogen nucleic
acids have to be taken up into the endolysosomal compart-
ment, where degradation allows the nucleic acids to become
available for TLR binding. Thus, synthetic mimics of viral
nucleic acids added directly to cells in vitro or used as adjuvants
in vivo in mouse models are unsuitable to investigate mechanisms
that allow the immune system to distinguish pathogen from
self-nucleic acids.
Nevertheless, “naked” pathogen-derived and self-nucleic acids
may be present in the extracellular space upon release from dam-
aged microbes or disintegrating infected and uninfected host
cells. Under physiological conditions, however, natural “naked”
nucleic acids are degraded by extracellular DNases and RNases
before they can access the endolysosomal compartment. Where
such degradation is defective, the danger emanating from released
self DNA becomes evident as seen in SLE patients carrying
mutations in DNase I and in DNase I-deficient mice, which
develop a lupus-like disease (Napirei et al., 2000; Yasutomo et al.,
2001). Interestingly, receptors for the uptake of nucleic acids such
as scavenger receptors and C-type lectin receptors (CLR) have
been described and seem to play a role in the uptake of syn-
thetic nucleic acid TLR agonists such as CpG ODN and polyI:C
(Zhu et al., 2001; Limmon et al., 2008; Lahoud et al., 2012).
However, synthetic nucleic acid TLR agonists with a phospho-
rothioate backbone and dsRNA homopolymers as commonly
used for experimental TLR activation are more resistant to enzy-
matic degradation than natural nucleic acids and a relevant role
of nucleic acid-binding scavenger receptors in delivering natu-
ral nucleic acids into the TLR-sensing endolysosomal compart-
ment under non-pathological conditions is highly questionable.
Thus, in order to understand how pathogen-associated nucleic
acids gain access to the TLR-sensing endolysosomal compartment
while self-nucleic acids are excluded from entering, it is neces-
sary to take into account which pathways are involved in uptake
of pathogens and dead cell material.
HOW IS THE UPTAKE OF PATHOGENS AND DEAD CELL
MATERIAL MEDIATED?
Since nucleic acids are typically not available at the surface of
pathogens, they are unlikely to play a role in pathogen uptake.
Furthermore, it has been shown that uptake of TLR agonists is
independent of TLR9, even in soluble form such as CpG ODN.
During infections, cells of the innate immune system internal-
ize pathogens for sampling by endosomal TLR by a number of
different ways: (1) by receptor-mediated endocytosis in response
to binding to scavenger receptors, (2) by phagocytosis which
is promoted by the complement system through opsonisation,
and (3) by Fc receptor (FcR)-mediated uptake upon opsonisa-
tion with antibodies (Figure 2). Similarly, material from infected
and uninfected dead cells is taken up by specialized cell types
such as macrophages and DC involving scavenger receptor-,
complement- and antibody-mediated uptake (Figure 2).
SCAVENGER RECEPTOR-MEDIATEDUPTAKE
Uptake of pathogens and pathogen-derived material is medi-
ated by scavenger receptors that are expressed among other cell
types by phagocytic macrophages and antigen-presenting DC.
Scavenger receptors encompass a group of structurally unre-
lated transmembrane surface molecules with relatively promiscu-
ous ligand binding characteristics such as scavenger receptor A
(SR-A), MARCO and CD36. This promiscuity allows scavenger
receptors to mediate uptake of a wide range of pathogens includ-
ing gram-positive and gram-negative bacteria, yeast, viruses and
parasites (Mukhopadhyay and Gordon, 2004). However, due to
the observed redundancy and the promiscuous and overlap-
ping ligand-binding characteristics of scavenger receptors, little is
known about their natural ligands and the structural basis for lig-
and binding. Interestingly, scavenger receptors are also involved
in the uptake of dead cell material by both macrophages and DC
(Peiser et al., 2002; Harshyne et al., 2003; Parlato et al., 2010).
In case of macrophages, clearance of dead cells is involved in
re-establishment of tissue homeostasis whereas DC ingest cel-
lular material to instruct and regulate T cell responses against
cellular and cell-associated antigens. Due to these functional dif-
ferences, the uptake of pathogens and dead cell material differs
quantitatively between macrophages and DC. In addition, qual-
itative differences in the pathways that mediate uptake by these
antigen-presenting cell types also exist. For example, it has been
shown that, unlike macrophages, DC acquire cell-associated anti-
gen from live cells via a SR-A-dependent uptake mechanisms
(Harshyne et al., 2003). However, the composition of the cellu-
lar material ingested by DC through “nibbling” on live cells is
unknown and it would be interesting to determine whether cellu-
lar nucleic acids are present in the cellular material that is taken up
or whether specific species of cellular nucleic acids are excluded.
In macrophages, the scavenger receptors MARCO and SR-A
are involved in uptake of CpG ODN and influence TLR9-
mediated IL-12 induction with MARCO enhancing and SR-A
reducing its production (Jozefowski et al., 2006). Interestingly,
the binding to SR-A is dependent on the presence of serum,
suggesting that CpG ODN may have to be available in form of
complexes with nucleic acid-binding proteins in order to bind
SR-A (Jozefowski et al., 2006). Similarly, the serum factor granulin
or its precursor pro-granulin binds to CpG ODN and medi-
ates uptake into the endolysosomal compartment probably by
a sortilin-dependent pathway (Park et al., 2011). Macrophages
from MARCO and SR-A deficient mice show the same oppos-
ing alterations in IL-12 induction in response to the TLR4 agonist
lipopolysaccharide suggesting that the modulation of TLR activa-
tion by scavenger receptors is not restricted to endosomal nucleic
acid-sensing TLR (Jozefowski et al., 2005).
COMPLEMENT-MEDIATED PHAGOCYTOSIS
In addition to scavenger receptor-mediated uptake, pathogens
and dead cell material can be ingested via complement receptor-
mediated uptake upon opsonisation with complement factors. In
contrast to live cells, which have the ability to actively remove
deposits of the complement cascade on their cell surface, dead
cells and pathogens are unable to do so and become opsonised
by complement factors (Trouw et al., 2008). For example, the
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FIGURE 2 | Mechanisms for uptake of pathogens and dead cells. Material
from pathogens and dead cells is taken up via the same uptake mechanisms,
which include Fc receptor-, complement receptor- and scavenger
receptor-mediated uptake. Fc receptor- and complement receptor-mediated
uptake require the prior opsonisation of the cargo with antibodies and
complement factors, respectively. APC activation is tightly regulated and
influenced both by the source of the material and uptake route. Uptake of
material from dying uninfected cells induces a number of regulatory
pathways which attenuate pro-inflammatory immunogenic antigen-presenting
cells (APC) activation. In contrast, uptake of pathogens or pathogen-derived
material as associated with infected dying cells leads to pro-inflammatory
immunogenic activation of APC.
complement component C1q binds to antibodies complexed with
antigen. This includes IgG and IgM antibodies bound to sol-
uble antigens, pathogens and dead cells. Interestingly, C1q has
also been shown to bind DNA and RNA, which is exposed on
the surface of dying cells in late apoptosis and is involved in
the degradation of DNA in cooperation with DNase I (Gaipl
et al., 2004; Palaniyar et al., 2004). Thus, binding and removal
of cellular DNA from dead cells by C1q presents one mecha-
nism that prevents the activation of the innate immune system
by self-nucleic acids. Furthermore, C1q inhibits NFκB activa-
tion in response to TLR stimulation, reducing the induction of
pro-inflammatory cytokines by monocytes, macrophages andDC
(Fraser et al., 2009). The important regulatory role of C1q in
preventing innate immune activation by dead cells accumulating
in the tissue is underpinned by the finding that C1q deficiency
leads to autoimmunity induction in humans and mice resulting
in SLE and SLE-like symptoms, respectively (Schur, 1977; Botto
et al., 1998). Defects in other proteins that are involved in the
removal of cell remains such as mutations in serum amyloid P,
milk fat globule-epidermal growth factor 8 and TAM receptor
protein tyrosinase kinase family also lead to lupus-like syndromes
(Bickerstaff et al., 1999; Paul and Carroll, 1999; Lu and Lemke,
2001; Hanayama et al., 2004). Interestingly, not all defects in
complement proteins participating in the removal of dead cells
from the tissue lead automatically to SLE-like symptoms, since
deficiencies in other complement components such as Mannan-
binding lectin (MBL) andC3 affect uptake of dead cells but do not
promote autoimmunity induction (Takizawa et al., 1996; Sekine
et al., 2001; Stuart et al., 2005). Taken together, these findings
support the hypothesis that the ability of C1q to instigate DNA
degradation and to regulate TLR-mediated NFκB activation may
represent characteristics of C1q function that are crucial for the
prevention of endosomal TLR activation by self-nucleic acids and
autoimmunity induction.
FcR-MEDIATED UPTAKE
Similar to opsonisation with complement, pathogens can
be opsonised with antibodies mediating uptake via FcR on
macrophages and DC. As for receptor- and complement-
mediated uptake, antibody-mediated uptake is not restricted to
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pathogens and is also observed for dead cells. In particular, IgM
was shown to bind to oxidation-specific epitopes exposed on late
apoptotic cells (Chang et al., 1999). Interestingly, IgM-mediated
uptake of apoptotic cells via Fcα/μR down-modulates inflam-
matory responses by regulating APC activation and inhibits
inflammatory and autoimmune diseases such as arthritis and SLE,
respectively (Kim et al., 2003; Chen et al., 2009b; Jiang et al., 2011;
Notley et al., 2011). Opsonisation with IgG and uptake by Fcγ
receptor (FcγR) can either promote or down-modulate activa-
tion of antigen-presenting cells depending on which FcγR family
members mediates uptake. Independent of activation, antigen
presentation is much more efficient for antigens taken up in form
of immune complexes via FcγR than for antigens ingested by
pinocytosis (Ivan and Colovai, 2006).
In addition to promoting uptake of pathogens and dead cells
through opsonisation, antibodies bound to antigen also trig-
ger the complement cascade and thus promote the killing of
pathogens and advance the phagocytosis of pathogens and dead
cells through further opsonisation with complement factors cre-
ating a potent feedback loop.
DIFFERENCES IN INGESTING PATHOGENS vs. DEAD CELL MATERIAL
None of the discussed uptake mechanisms for pathogens differ
fundamentally from those mediating uptake of dead cells. While
C1q- and IgM-mediated uptake of apoptotic cells is associated
with induction of regulatory pathways and crucial for prevent-
ing autoimmunity induction, their binding to dead cells is not
exclusive and they play an equally important role in uptake of
pathogens. This seems entirely reasonable since both dead cells
and pathogens represent entities that have to be removed in order
to restore tissue homeostasis. However, the hazards emanating
from uninfected dead cells are very different from those associated
with pathogens and infected dying cells and the immune system
has to be able to distinguish the two scenarios in order to prevent
autoimmunity induction. The discrimination between pathogen
and cellular nucleic acids ismost crucial for APCwith the capacity
to prime or promote antigen-specific T cell responses in response
to activation via nucleic acid sensing TLR.
DC AND THE DISCRIMINATION BETWEEN PATHOGEN AND
SELF NUCLEIC ACIDS
PDC and specific DC subsets specialized in cross-priming of viral
antigen-specific CD8 T cells seem to play particular but distinct
roles during virus infections (Belz et al., 2009). PDC are a cell type
specialized in virus recognition via TLR7 and TLR9 (Bao and Liu,
2013). They produce high systemic levels of IFN-I upon recogni-
tion of viral ssRNA or viral DNA and are, therefore, also known
as natural IFN-producing cells (Bao and Liu, 2013). High levels
of systemic IFN-I are a hallmark of viral infection and influence
the anti-viral immune response on many levels (Levy et al., 2011).
IFN-I drives the differentiation of monocytes into inflammatory
DC, promotes the T cell stimulatory activity of APC, supports
T helper cell-independent class switching of B cells, skews the T
helper response toward a Th1 phenotype and aids the induction
of cytotoxic T lymphocyte (CTL) responses by directly acting on
CD8 T cells (Le Bon and Tough, 2008). However, IFN-I produc-
tion in response to virus infection is not necessarily dependent
on PDC (Swiecki and Colonna, 2010). While it is accepted that
PDC are specialized in virus recognition and IFN-I production,
the role of PDC as antigen-presenting cells during virus infection
is less well understood. There are conflicting results on their endo-
cytic activity and their ability to present exogenous antigens and
it is evident that PDC differ from other DC subsets with regard
to the uptake and processing of exogenous antigens (Villadangos
and Young, 2008). However, PDC clearly take up virus particles.
Viruses such as influenza virus enter PDC via receptor-mediated
uptake into the TLR-sensing endolysosomal compartment, which
is their natural infection route (Patterson et al., 1979; Londrigan
et al., 2012). In contrast, fusogenic viruses such as Coxsackie virus
and foot-and-mouse-disease virus are dependent on the pres-
ence of anti-viral antibodies and complex formation for uptake
into endosomes via FcγR expressed by PDC (Guzylack-Piriou
et al., 2006; Wang et al., 2007). In addition to the recognition of
genomic viral material, PDC can become activated by viral ssRNA
replication intermediates, which accumulate in the cytoplasm
upon infection and are then shuttled into the endolysosomal
compartment for recognition by TLR7 by autophagy (Lee et al.,
2007). The initiation of virus-induced autophagy is driven by
cytoplasmic PRR and hence cytoplasmic self-nucleic acids are not
subject of translocation to the endolysosomal compartment in
uninfected cells (Tal and Iwasaki, 2009). Thus, under physiolog-
ical conditions, PDC usually do not encounter cellular nucleic
acids making a distinction between self-versus pathogen nucleic
acid dispensable for this cell type. However, once the regulatory
mechanism that prevent the release and accumulation of nucleic
acids from dead cells fail and allow for complex formation of cel-
lular RNA and DNA with antibodies or the antimicrobial peptide
LL37, PDC become a driving force for autoimmune induction as
observed in SLE and psoriasis, respectively (Lovgren et al., 2004;
Barrat et al., 2005; Lande et al., 2007; Ganguly et al., 2009).
Specific DC subsets such as mouse CD8α+ DC, the related
CD103+ DC and human BDCA3+ DC are specialized in the
uptake of cellular material from dying cells and cross-present
cell-associated antigen to CD8 T cells. While immature CD8α-
like DC are involved in peripheral tolerance induction, activated
CD8α-like DC prime CTL responses against cell-associated anti-
gens and thereby play a crucial role in anti-viral immunity (Joffre
et al., 2012). The cellular material that is taken up by this special-
ized DC subset is sampled in the endolysosomal compartment in
which TLR activation takes place. CD8α-like DC express TLR3
and TLR8 and, therefore, can detect viral dsRNA and theoreti-
cally also ssRNA associated with virus-infected cells (Schulz et al.,
2005). It is still entirely unclear how CD8α-like DC avoid the
activation by cellular RNA. The presence of gatekeeper recep-
tors with the ability to control or modulate the recruitment of
nucleic acid-sensing TLR to the endolysosomal compartment of
CD8α-like DC could play a role in avoiding the activation of these
cells in response to self-nucleic acids from uninfected dying cells.
The recruitment of nucleic acid-sensing TLR to the endolyso-
somal compartment could be initiated by gatekeeper receptors
upon sensing of non-nucleic acid PAMP or damage-associated
molecular patterns (DAMP) present in infected cells but absent
from uninfected cells (Figure 3B). Alternatively, CD8α-like DC
may be very selective regarding the cellular material that they
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FIGURE 3 | How are nucleic acid-sensing TLR recruited to the
endolysosomal compartment? (A) Nucleic acid sensing TLR traffic to
the endolysosomal compartment from the endoplasmic reticulum (ER) via
the Golgi apparatus. The chaperone protein UNC93B1 is necessary for
successful migration of all three endosomal TLR, and adaptor protein
(AP) complexes AP-2 an AP-4 are additionally required during the shuttle
process of TLR9 and TLR7, respectively. TLR9, but not TLR7, is
transiently located at the cell plasma membrane before reaching the
endolysosome. Similarly, TLR3 has been detected at the cell surface in
specific cell types. The reason for these differences in trafficking
pathways for endosomal TLR is currently unknown. While in the ER and
passing through the Golgi, TLR remain in an uncleaved state and only
undergo cleavage to attain functional activation after arrival in the
endolysosome. The requirement for cleavage is thought to be a
protective mechanism to avoid unwanted TLR activation outside the
endolysosomal compartment. (B) The induction and regulation of TLR
recruitment to the endolysosomal compartment is still poorly understood.
A small number of TLR have been detected in the endolysosomal
compartment in the absence of activating stimuli suggesting the
presence of a self-perpetuating low-frequency shuttling process of TLR to
the endolysosome (steady-state recruitment). During infection, high
frequency recruitment of TLR to the endolysosome takes place (induced
recruitment). Induced recruitment is likely to be initiated by
PAMP-activated TLR and/or other PRR. However, gatekeeper receptors
controlling pathways such as the CD24-Siglec or CLR-Syk pathway have
the ability to modulate and maybe even induce TLR recruitment to the
endolysosomal compartment. The presence of gatekeeper receptors with
the ability to distinguish specific signals from pathogens or uninfected
host cells and to promote or regulate TLR recruitment is likely to play an
important role in protecting the host from innate autoimmune activation.
ingest in order to reduce the uptake of self-nucleic acids. Mouse
CD8α+ DC and human monocyte-derived DC have been shown
to “nibble” on apoptotic cells rather than ingesting whole cells
(Schulz and Reis E Sousa, 2002; Harshyne et al., 2003). It is cur-
rently unclear what cellular components are present in the cellular
fragments that are taken up by CD8α-like DC. By restricting the
endocytosed material to membrane fragments, it may be possible
for CD8α-like DC to favor uptake of viral components that asso-
ciate with the plasma membrane as part of virus assembly and/or
viral budding processes and to avoid uptake of cellular nucleic
acids. A better understanding of the mechanisms underlying the
uptake of cellular material by CD8α-like DC could provide vital
insight into how discrimination between viral and self-nucleic
acids is achieved by these specialized APC.
WHATMECHANISMS AID IN THE DISCRIMINATION
BETWEEN VIRAL AND CELLULAR NUCLEIC ACIDS?
Since the uptake of pathogens and dead cells is not fundamentally
different, it is very likely that additional mechanisms have to be in
place to favor the recognition of viral nucleic acids and prevent the
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recognition of self-nucleic acids. Mechanisms that would allow
the innate immune system to discriminate between self and viral
nucleic acids could be based on the following characteristics: (1)
as discussed above total cellular nucleic acids contain enough
modified RNA species such as tRNA and rRNA which inhibit the
activation of endosomal TLR in the presence of stimulatory self-
nucleic acid such as mRNA; (2) sequestration of cellular nucleic
acids through binding to cellular components may prevent bind-
ing to endosomal TLR and/or (3) the recruitment of nucleic
acid-sensing TLR to the endolysosomal compartment or their
functional activation by cleavage may be regulated by gatekeeper
molecules sensing PAMP and/or DAMP absent from uninfected
dead cells or DAMP absent from infected dead cells. The evidence
for and the implications of the existence of these mechanisms and
their involvement in the discrimination between pathogen and
self-nucleic acids are discussed below.
(1) Modified cellular nucleic acids clearly can inhibit endo-
somal TLR activation by self-nucleic acids as discussed earlier
(Kariko et al., 2005). However, it is less clear how TLR activa-
tion by viral nucleic acids upon uptake of material from infected
cells is possible in the presence of modified cellular nucleic acids.
It is unclear whether or not viral nucleic acid species associated
with material from infected cells directly compete with cellular
nucleic acids including modified nucleic acid species for bind-
ing to endosomal TLR. If this is the case, virus-derived nucleic
acids have to be present in relative excess to trigger a response.
The ratio between viral and cellular nucleic acids present inside
infected cells is highly variable between viruses. While little is
known about quantitative and qualitative differences in bind-
ing of viral vs. cellular nucleic acids to TLR, relative binding
of RNA to polyribosomes in infected cells has been quantified.
Quantitative analysis of viral vs. cellular RNA for Semiliki forest
virus, herpes simplex virus and moloney murine leukaemia virus
excluded direct competition as a means for preferential transla-
tion of viral RNA in infected cells (Tuomi et al., 1975; Stringer
et al., 1977; Guttman-Bass et al., 1980). Thus, it is unlikely that
direct competition between viral and cellular RNA in infected
cells forms the general basis for preferential recognition of viral
RNA associated with infected cells by endosomal TLR.
(2) One example for sequestration of cellular DNA in dying
cells is high-mobility group protein B1 (HMGB1). HMGB1 binds
to DNA and interacts with nucleosomes, transcription factors and
histones. During early apoptosis HMGB1 binds tightly to chro-
matin within the dying cell as a consequence of underacetylation
and, thereby, prevents the release of HMGB1 and cellular DNA
even after the cells undergo secondary necrosis (Scaffidi et al.,
2002) (Figure 4). Thus, HMGB1 represents a prime example for
a molecule sequestering cellular nucleic acids in order to prevent
unwanted inflammation and immune responses in response to
cell death in the absence of infection.
However, HMGB1 also plays multiple roles in influencing the
induction of immune responses mediated through a number of
different receptors it can bind to. Upon release, HMGB1 can
signal through TLR2, TLR4, the receptor for advanced glyca-
tion endproducts (RAGE), CD24, Thrombin and CXCR4 (Yanai
et al., 2012). HMGB1 is released by monocytes, macrophages
and DC in response to TLR stimulation (Dumitriu et al., 2005).
Autocrine/paracrine HMGB1 plays a crucial role in DCmobiliza-
tion. Binding of HMGB1 to RAGE on DC controls the homing
of activated DC to the draining lymph node (Manfredi et al.,
FIGURE 4 | The nuclear protein HMGB1 holds diverse functions in
health and disease. HMGB1 is a ubiquitous nuclear DNA-binding
protein. During apoptosis, the binding of HMGB1 to chromatin tightens,
preventing the release of the cells’ nucleic acids into surrounding
tissue. In contrast, upon primary necrosis, complexes of HMGB1 and
chromatin are released into the extracellular space. Such complexes act
as alarmins, supporting tissue repair, and they have the capacity to
stimulate cytoplasmic nucleic-sensing PRR and TLR. It is currently not
entirely understood what factors favor the activation of a regulatory
rather than an immunogenic response by HMGB1. HMGB1 is also
released from antigen-presenting cells (APC) upon activation via PRR.
After binding to nucleic acids in surrounding tissue, HMGB1 can act in
an autocrine and paracrine fashion, signaling via a range of receptors
including TLR2/4, RAGE, CXCR4, and CD24.
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2008). Interestingly, engagement of RAGE by HMGB1 also pro-
motes the induction of IFN-I by PDC in response to CpG ODN
(Tian et al., 2007). However, as observed for TLR9, the binding
of ODN to HMGB1 seems to be affected by the sugar backbone
with natural phosphodiester ODN showing little binding in con-
trast to artificial phopshorothioate ODN. Furthermore, HMGB
proteins have been described as universal sentinels for nucleic
acids, since HMGB1-3 bind different nucleic acid species and
promote the activation of cytoplasmic and endosomal nucleic
acid-sensing PRR (Yanai et al., 2009). The activation of cytoplas-
mic and endosomal nucleic acid-sensing PRR is severely impaired
in the absence of HMGB proteins and the authors, therefore, pos-
tulated that binding of RNA and DNA to HMGB proteins may be
a general prerequisite for activation of nucleic acid-sensing PRR.
Alternatively, nucleic acid-binding to HMGB proteins may sup-
port ligand recognition by preventing nucleic acid degradation. In
this context, it is interesting to note that DC release HMGB1 upon
activation and thereby may aid the recognition of viral nucleic
acids in an inflammatory context (Dumitriu et al., 2005).
The seemingly opposing roles of HMGB1 in protecting innate
immune activation in response to cellular DNA and promoting
DC activation upon secretion in response to TLR stimulation
are difficult to reconcile. Furthermore, since neither HMGB1
nor the ssRNA- and DNA-sensing TLR are able to discriminate
between pathogen-derived and self-nucleic acids, the promotion
of endosomal TLR activation by nucleic acids bound to HMGB
proteins has the potential for disastrous consequences with regard
to autoimmunity induction. In support of this notion are the
findings that elevated expression levels of HMGB1 have been
detected in serum and in kidney of SLE patients, suggesting
that HMGB1 plays a role in autoimmune pathology (Jiang and
Pisetsky, 2008; Qing et al., 2008). Thus, the release of stimula-
tory nucleic acid-HMGB1 complexes from necrotic cells may have
to be regarded as a pathological situation. However, a physio-
logical role for such complexes cannot be entirely excluded and
it was argued that these complexes represent an alarmin with
the capacity to promote repair in damaged tissue (Yang et al.,
2007a). Interestingly, HMGB1 also binds to CD24, which trig-
gers the regulatory Siglec G pathway and, thereby, suppresses
immune activation in response to HMGB1-TLR4 signaling (Chen
et al., 2009a). While the CD24-Siglec pathway protects the host
from responding to pathological cell death, responses to PAMP
are unaffected by this pathway. As such, the CD24-Siglec path-
way may represent one example for a pathway with gatekeeper
function that allows the immune system to discriminate between
endogenous alarmins vs. pathogen-derived PAMP.
(3) Gatekeeper receptors with the ability to detect PAMP
and/or DAMP absent from uninfected cells are involved in the
recruitment or the cleavage of nucleic acid-sensing TLR to the
endolysosomal compartment would represent an additional pow-
erful mechanism for preventing the recognition of self-nucleic
acids upon uptake of cellular material from uninfected cells
(Figure 3B). While it is established that nucleic acid-sensing TLR
have to be recruited to the endolysosomal compartment upon
uptake of pathogens or cellular material, the exact mechanisms
of the recruitment remain unexplored. Initially, it was thought
that TLR9 is located in the ER in unstimulated cells and is
recruited to the endolysosomal compartment only after uptake
of TLR9 agonist (Latz et al., 2004). More recent findings indi-
cate that low level of trafficking of nucleic acid-sensing TLR
via the Golgi to the endolysosomal compartment takes place in
the steady state and that these few TLR molecules may initi-
ate TLR recruitment upon stimulation with nucleic acids (Ewald
et al., 2008; Park et al., 2008; Chockalingam et al., 2009; Blasius
and Beutler, 2010). This model is supported by the finding that
transgenic TLR-GFP is cleaved and transported to the endolyso-
somal compartment in unstimulated cells (Avalos et al., 2013).
Interestingly, TLR4 activation induces the recruitment of nucleic
acid-sensing TLR to the endolysosomal compartment, showing
that other pathways can influence TLR-mediated detection of
nucleic acids (Kim et al., 2008). Additional evidence that gate-
keeper receptors may regulate the recruitment and/or cleavage
of endosomal TLR stems from findings demonstrating that CpG
ODN-mediated TLR9-independent activation of the Src family
pathway at the cell surface of antigen-presenting cells is cru-
cial for the subsequent activation of NFκB via TLR9 (Sanjuan
et al., 2006). This study further indicated the indirect associa-
tion of TLR9 and Syk downstream of CpG-mediated activation
of the Src family pathway. Possible candidates for Syk recruitment
include ITAM- and ITIM-containing CLR, which play a role in
antigen-processing and -presentation in DC and other myeloid
cells (Kerrigan and Brown, 2010). While there is no direct evi-
dence for CLR acting as gatekeeper molecules with the capacity
to control the recruitment or the cleavage of nucleic acid-sensing
TLR, CLR are known to influence TLR-mediated immune activa-
tion of antigen-presenting cells (Dennehy et al., 2008; Ferwerda
et al., 2008; Meyer-Wentrup et al., 2009; Xaplanteri et al., 2009;
Jahn et al., 2010; Eberle and Dalpke, 2012).
CLR comprise a very heterogeneous family of molecules with a
carbohydrate recognition domain, whichmediates binding to car-
bohydrate structures of pathogen- or self-origin (Robinson et al.,
2006). The CLR DC-SIGN has been shown to down-modulate
activation in response to TLR stimulation via Raf-dependent
acetylation of NFκB (Gringhuis et al., 2007). DC-SIGN is a
CLR that has evolved to mediate cellular interactions by bind-
ing to ICAM-2 and ICAM-3. However, a number of mannose-
expressing pathogens, such as mycobacterium tuberculosis and
HIV, bind to DC-SIGN and down-modulate TLR-mediated
immune activation to their own advantage. While DC-SIGN
clearly has the ability to influence TLR-mediated activation, it is
primarily involved in the recognition of self-carbohydrate moi-
eties as part of intercellular interactions. It blunts rather than
promotes TLR-mediated activation and is, therefore, an unlikely
candidate for initiating the recruitment of TLR to the endolyso-
somal compartment.
Another pathway with the ability to detect PAMP which
has been shown to influence TLR-mediated immune activation
is the complement system. The anaphylatoxins C3a and C5a
increase NFκB activation and lead to enhanced induction of pro-
inflammatory cytokines such as IL-6 and TNFα in mouse and
human DC (Peng et al., 2006, 2008; Lalli et al., 2007; Li et al.,
2012). However, regulatory effects of anaphylatoxins have also
been described resulting in reduced induction of IL-12, IL-23, and
IL-27 (Hawlisch et al., 2005; Lalli et al., 2007). Recently, it was
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shown that N-glycan galactosylation of IgG1 antibody promotes
concurrent signaling via the CLR dectin-1 and the inhibitory
FcγRIIB receptor and, thereby, exerts anti-inflammatory influ-
ence on C5a-mediated inflammatory responses (Karsten et al.,
2012). The frequency of galactosylated serum IgG decreases under
pro-inflammatory conditions such as during infection or in
autoimmune disease (Karsten et al., 2012). Thus, the regulation of
N-glycan galactosylation of IgG seems to represent an additional
mechanism to dampen unwanted pro-inflammatory responses in
an uninfected host.
The crosstalk between complement and TLR activation is a
perfect example for how two independent PRR systems that are
triggered by separate sets of PAMP can converge and provide pos-
itive feedback for increased innate immune activation. However,
it is still poorly understood why complement activation enhances
cytokine induction in response to PRR activation in some situ-
ations and dampens the response in others. Further insight into
the factors that determine under which conditions complement
promotes or suppresses TLR-mediated immune activation may
lead to a better understanding of how innate immune activa-
tion in response to sterile cell death and the release of potentially
stimulatory self-nucleic acids is avoided.
CONCLUSION
In conclusion, we put forward the hypothesis that the sens-
ing of naked ssRNA and DNA, which is not associated with
pathogen-derived material including non-nucleic acid PAMP,
represents a precarious feature of the immune system. It doesn’t
allow for the discrimination between pathogen-associated vs.
self-nucleic acids and, therefore, has the potential to lead to
autoimmunity. Hence, any mechanisms that allow for or pro-
mote the recognition of naked ssRNA and DNA such as in form
of immune complexes should be regarded as non-physiological
events. Furthermore, we propose that the discrimination between
pathogen-derived and self-nucleic acids can be based on at least
three separate mechanisms alone or in combination: (1) avoid-
ance of uptake of self-nucleic acids in a form that allows TLR
binding, (2) association of self-nucleic acids with cellular compo-
nents that prevent TLR binding and (3) the presence of gatekeeper
receptors, which control the recruitment of TLR to the endolyso-
somal compartment. Identification of the mechanisms that favor
the recognition of pathogen-associated nucleic acids and limit
TLR-mediated activation in response to self-nucleic acids will
be instrumental for developing more refined strategies to exploit
activation of endosomal TLR in the context of vaccines and tumor
immunotherapy and for gaining a better understanding of the
processes that can lead to autoimmunity induction.
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